about
Eating disorders in schizophrenia: implications for research and managementLong-term drug treatment for obesity: a systematic and clinical reviewSevere loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment studyFluoxetine for adult overweight or obese peopleIs increased antidepressant exposure a contributory factor to the obesity pandemic?Treating comorbid anxiety and depression: Psychosocial and pharmacological approachesPeripheral Serotonin: a New Player in Systemic Energy HomeostasisCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersAntidepressant efficacy of agomelatine: meta-analysis of published and unpublished studiesChanges in body weight and psychotropic drugs: a systematic synthesis of the literatureEffects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent ratsThe efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patientsAnxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.A General Framework for Considering Selection Bias in EHR-Based Studies: What Data Are Observed and Why?Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trialsFluoxetine augments ventilatory CO2 sensitivity in Brown Norway but not Sprague Dawley ratsMetabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general populationSerotonin transporter deficiency drives estrogen-dependent obesity and glucose intoleranceDistinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research.Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation studyNIDDK international conference report on diabetes and depression: current understanding and future directionsPsychological changes following weight loss in overweight and obese adults: a prospective cohort study.Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi-Ethnic Study of Atherosclerosis.Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis.Review of the use of mirtazapine in the treatment of depression.Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetineLevomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension studyObesity and cognitive decline: role of inflammation and vascular changes.Depressive symptoms and cardiovascular health by the American Heart Association's definition in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studyDepression symptoms in people with diabetes attending outpatient podiatry clinics for the treatment of foot ulcers.Concerns over participant suicides prematurely abort a clinical trial of potentially significant impact on public health: how will we make progress in timid times?Obstructive sleep apnea and psychiatric disorders: a systematic reviewAntidepressant use and body mass index change in overweight adolescents: a historical cohort study.Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.Chronic fluoxetine increases extra-hippocampal neurogenesis in adult mice.
P2860
Q21284525-7FB38DAB-6ECF-4BD4-BE3A-CAD89ACBF7C1Q22253010-66DD1BC5-28C7-437A-89AC-0F0B8DBED71EQ22305776-4107C197-55EA-4C01-94BB-0DE879749A9BQ24188314-DDEFCABD-5DE0-41C8-AD66-C08F77EFD948Q26765430-5E7CDF51-84CB-4766-99B2-D5042046F28AQ26770334-77EC4461-B11C-49A1-99D9-3F08F704DCB3Q26775537-D712656A-9D99-49F2-B9B1-EF45A86FFE24Q27009995-2BB26453-9BEB-4CCC-9CB0-905D0605D708Q28236293-9B08CC62-E037-4176-ABE2-3F753654F64FQ28728401-A840B798-D9BF-4E5F-B61F-124DF99BBECDQ30373410-504E7171-3E14-40B6-BB09-06899A083723Q30449347-215B88F9-9CF1-4D01-A174-3A35F85BD98AQ30534769-20CEF051-5F4C-4E39-B206-A6CC67DFF9ABQ30665994-99CD2C5D-DF28-4FDE-9DB4-7A863B952637Q31133096-B5A35404-870C-4DAB-9926-62AB68DAB5E7Q32126634-2EC6685A-338B-47EA-941E-62B455750E3BQ33582272-96D9BD54-D615-44D8-BF0B-FB0BB9035161Q33622056-BBF92DB3-1DF1-4B91-927B-94B83EC5E3CCQ33682164-E29EFD61-9799-4563-BEFF-B3E52FA731DAQ33707304-9AE0AC49-A348-4F6B-816D-A2E5354ED2E4Q33827099-10A82910-61EA-49FA-92C2-6B3E369B0DA4Q33960231-A63AF068-3D3F-4FB3-A240-DD585E86C264Q34011175-A250E9A8-CC5C-4B8B-8D13-106CAD766B0FQ34033259-B186005E-6173-4917-BF80-E9A80DACC7D4Q34053569-2BC34CF3-338B-4DC9-B331-AD0AF8F6CDC8Q34159724-4C530625-CCBD-4905-BFE9-CBA136681CA2Q34190102-5C2CD8AE-276C-4C37-928F-370274508466Q34243328-2FA2808E-C5D2-4055-B99A-22911C420DD0Q34256005-0A638233-8341-406A-BB55-E549B7DC0757Q34369664-1D95411F-7D6E-46FE-A316-67ED458BF467Q34531545-7D040946-F3A0-417C-ABEF-A26B5772D8BEQ34540572-52AD0CF4-7765-4EA1-A6F4-6F508DDA623EQ34541151-3F25F653-4889-4399-90FD-F331D54DCDEBQ34579155-3594B9D0-08DF-424B-BD36-1E24F9403523Q34749964-7E9E9951-564C-40B8-978A-092231E69F07Q34983960-BB5CD741-49D2-445D-98C8-4898C81B2EC3Q34992286-AA72199F-7188-438D-85FC-BC2A21FC30B7Q34996871-BDC9FDC2-AAD5-4F60-803A-7AC140FCA244Q35169141-4B3F8B2D-C4D3-4747-85FF-26586B69B75DQ35178982-5EFA4CDA-1C76-4839-A0EC-3113E3FD9FB3
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antidepressants and Body Weight
@ast
Antidepressants and Body Weight
@en
Antidepressants and Body Weight
@en-gb
Antidepressants and Body Weight
@nl
type
label
Antidepressants and Body Weight
@ast
Antidepressants and Body Weight
@en
Antidepressants and Body Weight
@en-gb
Antidepressants and Body Weight
@nl
altLabel
Antidepressants and body weight: a comprehensive review and meta-analysis
@en
prefLabel
Antidepressants and Body Weight
@ast
Antidepressants and Body Weight
@en
Antidepressants and Body Weight
@en-gb
Antidepressants and Body Weight
@nl
P3181
P356
P1476
Antidepressants and Body Weight
@en
P2093
Laura Mandelli
P304
P3181
P356
10.4088/JCP.09R05346BLU
P407
P577
2010-10-15T00:00:00Z